To promote collaborative research, provide guidelines and standards for body fluid biomarker research leading to well validated assays for the diagnosis, prediction and monitoring of disease outcomes and treatment efficacy in the field of multiple sclerosis and related disorders within Europe and worldwide.
To be the leading European network of researchers in the field of body fluid biomarkers in multiple sclerosis and related disorders.
Biomarkers in body fluids offer additional insight into multiple sclerosis (MS) pathogenesis, disease characteristics of different MS phenotypes and responses to therapeutics. Excellent cerebrospinal fluid (CSF) biomarker research for MS cannot be performed by single research centers, since it is difficult to obtain sufficient numbers of samples for biomarker evaluation. The European leading research groups on CSF biomarkers for MS have formed the BioMS-network to collaborate and optimize CSF biomarker research.